Critical assessment of current adeno-associated viral vector production and quantification methods, Biotechnol Adv, vol.26, pp.73-88, 2008. ,
Manufacturing of recombinant adenoassociated viral vectors for clinical trials, Mol Ther Methods & Clin Dev, vol.3, p.16002, 2016. ,
Improving the quality of adeno-associated viral vector preparations: the challenge of product-related impurities, Human gene Ther Methods, vol.28, pp.101-109, 2017. ,
A call to arms for improved vector analytics! Human gene, Ther Methods, vol.26, pp.1-2, 2015. ,
Characterization of a recombinant adenoassociated virus type 2 Reference Standard Material, Hum Gene Ther, vol.21, pp.1273-85, 2010. ,
Manufacturing and characterization of a recombinant adenoassociated virus type 8 reference standard material, Hum Gene Ther, vol.25, pp.977-87, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-01847281
Recombinant adeno-associated viral vector reference standards, Methods Enzymol, vol.507, pp.297-311, 2012. ,
International efforts for recombinant adeno-associated viral vector reference standards, Mol Ther, vol.16, pp.1185-1193, 2008. ,
FDA statement regarding the use of adeno-associated virus reference standard materials, Human gene Ther Methods, vol.26, p.3, 2015. ,
Absolute determination of single-stranded and self-complementary adeno-associated viral vector genome titers by droplet digital PCR, Human gene Ther Methods, vol.25, pp.115-140, 2014. ,
Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR, Mol Ther Methods Clin Dev, vol.5, p.16019, 2016. ,
Good manufacturing practice production of self-complementary serotype 8 adeno-associated viral vector for a hemophilia B clinical trial, Hum Gene Ther, vol.22, pp.595-604, 2011. ,